- Jaishankar wraps up New York leg of US visit, to travel to Washington between Sep 27-30
- RBI cancels licence of Kapol Cooperative Bank in Mumbai
- WII team inspects Alipiri footpath
- KCR advises people take safety measures during Ganesh idol immersion
- Chiefs of Indo-Pacific Armies agree on joint action plan to tackle challenges in region
- Chandrapur sarpanch receives Union Tourism Award
- 'Amit Shah assured that murderers will be punished', Manipur CM on students' killing
- Asian Games: Sift Kaur wins gold with world record as shooters make India's day; Vishnu Saravanan wins bronze in sailing
- DUTA polls record 85% voting, counting underway
- IT Department searches offices of Chinese electronic giant Lenovo in Mumbai, Bengaluru, Gurugram
Plasma therapy not beneficial: ICMR Study
Use of convalescent plasma therapy in Coronavirus-infected patients does not help in reducing mortality or progression to severe COVID-19, a multi-centric study funded by the Indian Council of Medical Research (ICMR) has found
New Delhi: Use of convalescent plasma therapy in Coronavirus-infected patients does not help in reducing mortality or progression to severe COVID-19, a multi-centric study funded by the Indian Council of Medical Research (ICMR) has found.
The 'open-label parallel-arm phase II multicentre randomized controlled trial' (PLACID Trial) was conducted across 39 public and private hospitals across India between April 22 to July 14 to investigate the effectiveness of convalescent plasma (CP) for the treatment of COVID-19, it said.
The convalescent plasma (CP) therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those antibodies into an active coronavirus patient to help kickstart the immune system to fight the infection.
A total of 464 participants (moderately ill COVID-19 patients admitted to hospitals) were enrolled for the study, which has not yet been peer-reviewed and has appeared on medRxiv, a preprint server.
The National Task Force for COVID-19, a committee formed by the ICMR to respond to the pandemic, has reviewed and approved this study, it said.